Product Description

Anti-Influenza B virus HA/Hemagglutinin Reference Antibody (Lesofavumab, RUO)

Sizes: 100ug, 1mg

Catalogue Numbers: VK515056-100, VK515056-1000

Lead times: 1-2 weeks, if manufacturer has product in stock

Manufacturer/Ship Location: China

Description: Lesofavumab is a recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing Lesofavumab (RG6024), a monoclonal antibody, for the treatment of influenza B infections.

Reactivity: Influenza B virus

Host: Human

Applications: ELISA, Bioactivity: FACS, Functional assay

Alternate Names: RG6024, RG6024, MHAB5553A, RG70026, RO7045557, 1807960-57-1

Clonality: Monoclonal

Isotype: IgG1, kappa

Target: HA/Hemagglutinin

Purification: Protein A/G purified from cell culture supernatant.

Purity: >95% purity as determined by SDS-PAGE.

Expression System: Mammalian Cells

Storage and Stability: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

Storage Buffer: 0.01M PBS, pH 7.4.

Form: Liquid

Accession: P03461

Endotoxin Level: Please contact the lab for this information.

Research Use Only